By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Ultrasal-er
Drugs

Ultrasal-er

https://themeditary.com/drug/ultrasal-er-7662.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 16, 2023  Additional Content by TheMediTary.Com

Generic name: salicylic acid topical [ sal-i-sil-ik-as-id-top-ik-al ]

Dosage form: topical solution

Medically reviewed by Drugs.com. Last updated on Dec 8, 2021.

Rx only

FOR TOPICAL USE ONLY.

NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

DESCRIPTION

UltraSal-ER is a topical preparation containing 28.5% salicylic acid extended release in a proprietary film-forming virucidal solution composed of acrylates copolymer, butyl acetate, carthamus tinctorius seed oil, cocamidopropyl dimethylamine, ethylhexylglycerin, isopropyl alcohol, isopropyl-metacresol, olea europaea fruit oil, phenic acid, phenoxyethanol, polysorbate 80, polyvinyl butyral, trimethyl pentanyl diisobutyrate, and water. The pharmacologic activity of UltraSal-ER is generally attributed to the keratolytic activity of salicylic acid, which is incorporated into a polyacrylic, film-forming virucidal solution designed to cover the wart without the need for a bandage. The structural formula of salicylic acid is:

ultrasal-5-01.jpg

CLINICAL PHARMACOLOGY

Although the exact mode of action for salicylic acid in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses. UltraSal-ER incorporates a unique patented extended release form of salicylic acid that provides for enhanced release of salicylic acid for over 24 hours.

The virucidal complex incorporated into UltraSal-ER’s proprietary solution is designed to help reduce risk of reinfection at the wart site, as well as prevent viral contamination of the product under normal usage.

INDICATIONS AND USAGE

UltraSal-ER is indicated for the topical treatment and removal of common warts and plantar warts.

CONTRAINDICATIONS

Patients with diabetes or impaired blood circulation should not use UltraSal-ER. UltraSal-ER also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face.

PRECAUTIONS

UltraSal-ER is for external use only. Do not permit UltraSal-ER to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. UltraSal-ER should not be allowed to contact normal skin surrounding the wart site, since localized irritation may occur. Treatment should be discontinued if excessive irritation occurs.

UltraSal-ER is flammable. Keep away from fire or flame. Keep bottle tightly capped when not in use.

ADVERSE REACTIONS

A localized irritant reaction may occur if Ultrasal-ER is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

DOSAGE AND ADMINISTRATION

Prior to applying UltraSal-ER, soak wart in warm water for five minutes. Remove any loose tissue by gently rubbing with a washcloth, emery board, or pumice stone. Dry the wart site thoroughly. Using the brush applicator supplied, apply UltraSal-ER twice to the entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day as directed by your healthcare provider. Be careful not to apply to surrounding skin.

Clinically visible improvement normally occurs during the first or second week of therapy. Resolution may be expected after four to six weeks of UltraSal-ER use, though some warts may take longer to remove.

HOW SUPPLIED

UltraSal-ER is supplied in 10 mL amber bottles with a brush applicator (NDC 42783-323-10).

Store at 15° to 30°C (59° to 86°F).

Manufactured for:

Elorac, Inc.

Vernon Hills, IL 60061

U.S. Patent No. 6, 979, 440

Additional Patent Pending

© 2014 Elorac, Inc.

1/2014

211909

PATIENT INSTRUCTIONS

Your health care provider has prescribed UltraSal-ER, a topical prescription preparation for the treatment of common warts and plantar warts. In order for UltraSal-ER to work properly and to ensure maximum benefit, the following instructions should be followed carefully. Of course, as with any medication, always consult your health care provider if you experience any discomfort or unexpected reactions.

ultrasal-5-04.jpg

STEP 1

WASH

  • Soak wart area in warm water for about 5 minutes.
  • Remove any loose tissue using a washcloth, emery board, or pumice stone.
  • Dry thoroughly.

ultrasal-5-05.jpg

STEP 2

BRUSH

  • Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second.
  • Be careful not to apply to surrounding skin.
  • Leave UltraSal-ER on wart area after it dries.

Repeat Step 1 and Step 2 once or twice daily as advised by the health care provider.

ultrasal-5-06.jpg

Clinically visible improvement will normally occur during the first or second week of therapy. Resolution may be expected after four to six weeks of UltraSal-ER use, though some warts may take longer to remove.

ultrasal-5-07.jpg

Vernon Hills, IL 60061

Frequently asked questions

  • Does duct tape really remove warts?

More about UltraSal-ER (salicylic acid topical)

  • Check interactions
  • Compare alternatives
  • Side effects
  • Breastfeeding
  • En español

Patient resources

  • UltraSal-ER drug information

Other brands

Wart Remover, Compound W, CeraVe SA Renewing, Dermarest Psoriasis Skin Treatment, ... +63 more

Professional resources

  • Ultrasal-ER prescribing information

Related treatment guides

  • Warts

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drug Status
Availability Rx and/or OTC Rx

Availability: Rx and/or otc

Pregnancy & Lactation: Risk data not available

Brand names: Wart remover, Bensal hp, Compound w, Dermalzone, Dermarest psoriasis skin treatment

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Ultrasal-er?

Salicylic acid is a keratolytic (peeling agent) that causes shedding of the outer layer of skin.

UltraSal-ER (for the skin) is used in the treatment of acne, dandruff, seborrhea, or psoriasis, and to remove corns, calluses, and warts.

UltraSal-ER may also be used for purposes not listed in this medication guide.

Warnings

UltraSal-ER can cause a rare but serious allergic reaction or severe skin irritation. Stop using this medicine and get emergency medical help if you have: hives, itching; difficult breathing, feeling light-headed; or swelling of your face, lips, tongue, or throat.

How should I use Ultrasal-er

UltraSal-ER is available in many different forms, such as liquid, gel, lotion, cream, ointment, foam, soap, shampoo, cloth pads, and skin patches.

Use exactly as directed on the label, or as prescribed by your doctor.

Do not take by mouth. Topical medicine is for use only on the skin.

UltraSal-ER can cause a rare but serious allergic reaction or severe skin irritation. Apply a very small amount of the medicine as a "test dose" to 1 or 2 small skin areas every day for 3 days in a row. If you do not have a reaction to the medicine, begin using your full prescribed amount on the 4th day.

You may need to shake the medicine before use. Follow all directions on the product label.

Do not use UltraSal-ER to treat any condition that has not been checked by your doctor.

Your symptoms may not improve for several days. Call your doctor if your symptoms do not improve, or if they get worse.

Store this medicine in the original container at room temperature, away from moisture and heat.

Keep the foam canister away from open flame or high heat. The canister may explode if it gets too hot. Do not puncture or burn an empty aerosol canister.

Detailed UltraSal-ER dosage information
Ultrasal-er Dosage information (more detail)

Before Taking

You should not use UltraSal-ER if you are allergic to it.

Using UltraSal-ER in a child or teenager with flu symptoms or chickenpox can cause a serious or fatal condition called Reye's syndrome.

Ask a doctor or pharmacist if this medicine is safe to use if you have:

  • liver or kidney disease;

  • diabetes; or

  • blood circulation problems.

Ask a doctor before using this medicine if you are pregnant or breastfeeding.

What happens if I miss a dose?

UltraSal-ER is used when needed. If you are on a dosing schedule, skip any missed dose. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medicine.

What should I avoid while using Ultrasal-er?

Avoid using UltraSal-ER on open wounds or on sunburned, windburned, dry, or irritated skin.

Rinse with water if this medicine gets in your eyes or mouth.

This medicine may be flammable. Do not use near high heat or open flame. Wash the medicine off your hands before handling a hair styling appliance (such as a curling or straightening iron). High heat could cause the medicine to ignite and burn your skin. Do not smoke until the gel has completely dried on your skin.

Avoid using other medications on the areas you treat with UltraSal-ER, unless you doctor tells you to.

Ultrasal-er side effects

UltraSal-ER can cause a rare but serious allergic reaction or severe skin irritation. These reactions may occur just a few minutes after you apply the medicine, or within a day or longer afterward.

Stop using UltraSal-ER and get emergency medical help if you have signs of an allergic reaction: hives, itching; difficult breathing, feeling light-headed; swelling of your face, lips, tongue, or throat.

Also stop using UltraSal-ER and call your doctor at once if you have:

  • severe headache, ringing in your ears, problems with hearing, thinking problems;

  • severe stomach pain, vomiting, or diarrhea;

  • a light-headed feeling, like you might pass out;

  • shortness of breath; or

  • severe burning, dryness, or irritation of the skin.

Common side effects of UltraSal-ER may include:

  • minor skin irritation, rash, or peeling; or

  • changes in the color of treated skin (usually whitening).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Ultrasal-er Side Effects

What other drugs will affect Ultrasal-er?

Medicine used on the skin is not likely to be affected by other drugs you use, but many drugs can interact. Tell your doctor about all your current medicines, including prescription and over-the-counter medicines, vitamins, and herbal products.

More about Ultrasal-er (Salicylic acid topical [ sal-i-sil-ik-as-id-top-ik-al ])

Dosage information
Ultrasal-er Side Effects
Ultrasal-ER Prescribing Information
Drug images
Side effects
Breastfeeding Warnings
Drug class: Drugs

Related treatment guides

Warts
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by